Netherlands· NL-a7805e34d18e

Moxifloxacine Sandoz 400 mg, filmomhulde tabletten

A moxifloxacin product containing moxifloxacinehydrochloride, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC J01MA14

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about moxifloxacinehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Moxifloxacin is registered in 16 of 19 countries.

Countries holding a registration under ATC J01MA14 (moxifloxacin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search moxifloxacin products by name

Moxifloxacin · ATC J01MA14

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of moxifloxacin costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $1.34 in United States to $6.89 in Switzerland — a ×5.2 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Moxifloxacin · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

CH Switzerland$6.89
IT Italy$1.99
US United States$1.34 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: MOXIFLOXACINEHYDROCHLORIDE
Manufacturer: Sandoz B.V.
Country: Netherlands (NL)
ATC code: J01MA14
ATC class: Moxifloxacin
Defined daily dose: 0.4 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
116180

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

531 interactions on record for moxifloxacin.

Graded by severity as the source publishes them — 175 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check moxifloxacin against other medicines How interaction checks work

Moxifloxacin · interactions on record

531 records

175 severe
140 moderate
49 minor
92 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
OndansetronA04AA01severe
GranisetronA04AA02severe

75 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Moxifloxacin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All moxifloxacin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Avelox, Moxifloxacin 1a Pharma
Belgium · Avelox, Kanavig
Bulgaria · Cimocinox, Moxifloxacin Kabi
Cyprus · Avelox, Erelan
Czechia · Avelox, Moxifloxacin Brown & Burk
Germany · Avalox, Moxifloxacin 1 A Pharma
Denmark · Moxifloxacin Accord, Moxifloxacin Fresenius Kabi
Estonia · Avelox, Floxelan
Spain · Abimox, Actira
Finland · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
France · Izilox, Moxifloxacine Arrow
United Kingdom (Northern Ireland) · Avelox, Moxidox
Greece · Avelox, Mikrobiel
Croatia · Melvedok, Moksacin 5 Mg/Ml Kapi
Hungary · Moxibiot, Moxifloxacin Anfarm
Ireland · Moxifloxacin
Iceland · Vigamox
Italy · Avalox, Moxidrop
Lithuania · Avelox, Ekara
Luxembourg · Avelox, Kanavig
Latvia · Avelox, Ekara
Malta · Erelan, Moxifloxacin Anfarm
Norway · Xinaflox
Poland · Flomixa, Floxamic Neo
Portugal · Avelox, Bluesar
Romania · Avelox, Kimoks
Sweden · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
Slovenia · Kimoks, Moksifloksacin Kabi
Slovakia · Avelox, Moloxin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fd99a645-7c90-4a05-98a0-9fd06d752f37
GET /v1/drugs/fd99a645-7c90-4a05-98a0-9fd06d752f37?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h116180_smpc.pdf",
  "strength": null,
  "atc_label": "Moxifloxacin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg116180",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "KARMIJN (E120)",
    "MACROGOLSTEARAAT, TYPE I",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "NATRIUMZETMEELGLYCOLAAT",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "MOXIFLOXACINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h116180.pdf",
  "authorised_at": "2015/03/16",
  "procedure_number": "AT/H/0366/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "116180",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about moxifloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console